<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19785" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Complement Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mollah</surname>
            <given-names>Fatema</given-names>
          </name>
          <aff>California Pacific Medical Center, San Francisco, CA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tam</surname>
            <given-names>Schuman</given-names>
          </name>
          <aff>University of California, San Francisco</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fatema Mollah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Schuman Tam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19785.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The complement system is a crucial part of the innate humoral immune system. The purpose of the complement system is to orchestrate opsonization, facilitate cytotoxic destruction and formulate membrane attack complexes (MAC), and liberation of peptides that promote the inflammatory response. Complement deficiencies are primary immunodeficiencies that cause various clinical scenarios depending on the specific complement protein that is deficient. This activity outlines the evaluation and management of complement deficiency and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of complement deficiency.</p></list-item><list-item><p>Outline the appropriate evaluation of complement deficiency.</p></list-item><list-item><p>Review the management options available for complement deficiency.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to advance the management of complement deficiency and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19785&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19785">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19785.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The immune system is the body&#x02019;s defense mechanism against infections and is made of two pathways - the innate pathway and the adaptive pathway.<xref ref-type="bibr" rid="article-19785.r1">[1]</xref>&#x000a0;The innate pathway is present from birth and is pre-programmed. The innate immune system consists of the cellular component, which includes monocytes, macrophages, and natural killer cells, and the humoral component, which includes the complement system. The adaptive pathway develops during life with exposure to infection and increases affinity with experience. It consists of the cellular component, which is T cells, and the humoral component, which consists of antibodies made by B cells. The adaptive pathway facilitates improved destruction of the organism as well as forms memory cells for future infections.</p>
        <p>Complement deficiencies are primary immunodeficiencies that cause&#x000a0;various clinical&#x000a0;scenarios&#x000a0;depending on the specific complement protein that is deficient.&#x000a0;This can include an increased&#x000a0;risk of a wide range of infectious as well as&#x000a0;local or systemic inflammatory and thrombotic conditions.<xref ref-type="bibr" rid="article-19785.r2">[2]</xref>&#x000a0;Additionally,&#x000a0;the complement system does not only act as the defense mechanism against infections it also works as a mediator in both the prevention of immune complex-related diseases and pathogenesis, such as systemic lupus erythematosus (SLE).<xref ref-type="bibr" rid="article-19785.r3">[3]</xref><xref ref-type="bibr" rid="article-19785.r4">[4]</xref><xref ref-type="bibr" rid="article-19785.r5">[5]</xref>&#x000a0;See<bold> Figure.</bold> Complement Cascade Schematic Diagram.</p>
      </sec>
      <sec id="article-19785.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Complement deficiencies are usually hereditary. The most common type is autosomal recessive form, including C1, C2, C3, C4, C5, C6, C7, C8, C9, and Mannan-binding lectin deficiencies.<xref ref-type="bibr" rid="article-19785.r2">[2]</xref>&#x000a0;The X-linked recessive pattern has been described for properdin deficiency.<xref ref-type="bibr" rid="article-19785.r6">[6]</xref> Other complement deficiencies are acquired through complement overconsumption, protein synthesis dysfunction, protein loss disorders, autoimmunity, and high catabolic states. Deficiencies of early components of the classical complement pathway, including C1, C4, and C2, are associated with encapsulated bacterial infections like <italic toggle="yes">Streptococcus Pneumoniae</italic> and <italic toggle="yes">Haemophilus Influenza</italic>&#x000a0;type b.<xref ref-type="bibr" rid="article-19785.r7">[7]</xref> A deficiency of C3 is associated with severe recurrent pyogenic infections early in life.<xref ref-type="bibr" rid="article-19785.r8">[8]</xref> Deficiencies of the late common pathway (C5, C6, C7, C8, and C9) are associated with increased Neisseria infections, including <italic toggle="yes">Neisseria meningitidis </italic>and<italic toggle="yes"> Neisseria gonorrhoeae</italic>. A deficiency of properdin in the early alternative pathway is also associated with recurrent Neisseria infection.<xref ref-type="bibr" rid="article-19785.r9">[9]</xref> A deficiency of mannan-binding lectin has been linked to an increased frequency of pyogenic infections and sepsis, particularly in children and neonates, when the adaptive immune system has not been matured. In addition to increased incidence of infection, an individual with early classical complement deficiency (C1, C4, or C2) frequently has a higher incidence of autoimmune disorders, especially systemic lupus erythematosus.<xref ref-type="bibr" rid="article-19785.r10">[10]</xref> Early classical complements like C1 bind to cells undergoing apoptosis and facilitate the elimination of such cells. The body produces autoantibodies against these uncleared cells that result in autoimmune disorders.</p>
      </sec>
      <sec id="article-19785.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Complement deficiencies are rare worldwide;&#x000a0;high-risk populations are screened to estimate prevalence. The mannan-binding lectin (MBL) of the lectin-based pathway is the most prevalent form of complement deficiency at 5% of the White population and it may be clinically silent. Apart from the MBL pathway, complement deficiencies are prevalent in 0.03% of the population.<xref ref-type="bibr" rid="article-19785.r11">[11]</xref>&#x000a0;Deficiency of C2 protein is the second most common form after MBL deficiency and is also clinically silent. C3 is a crucial player in the complement system as this protein is the last step of the early pathway, a precursor to C3a the anaphylatoxin as well as a facilitator of chemotaxis for neutrophils and macrophages. Among all patients with primary immunodeficiency diseases, approximately 5% have complement deficiency. The most common type of primary immunodeficiency is antibody deficiency consisting of approximately 65% of the cases.</p>
        <p>In&#x000a0;the cases of meningococcal infection, the prevalence rate is&#x000a0;nearly 30%.&#x000a0;Patients with C1q deficiency are observed to have a 93% chance of having SLE in the future. Similarly, C1rs deficiency is found to have a 57% association with SLE, and C4 deficiency&#x000a0;is associated with a 75% association with SLE.</p>
        <p>Properdin and C2 deficiencies have been more commonly observed in the White population, C6 deficiencies have been observed to have a predisposition in Africans, and deficiencies in C8 and C9 are more commonly seen in Asian populations. Specifically, two distinct C8 deficiency states have been studied: C8 alpha-gamma deficiency that is seen mostly in Afro-Caribbeans, Hispanics, and Japanese; and C8beta, mainly evident in Whites.</p>
      </sec>
      <sec id="article-19785.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The complement system is a crucial part of the innate humoral immune system. The purpose of the complement system is to orchestrate opsonization, facilitate cytotoxic destruction and formulate membrane attack complexes (MAC), and the liberation of peptides that promote the inflammatory response.<xref ref-type="bibr" rid="article-19785.r12">[12]</xref>&#x000a0;The complement system consists of 3 pathways, the classical, alternative, and lectin, that are initiated by distinct mechanisms. The classical pathway is initiated by C1, C2, C4, and antigen-antibody immune complex. The lectin pathway is initiated by lectins, mannose-binding protein, sugar residues on the microbial surface, C4, and C2. The alternative pathway is initiated by C3, factor B, factor D, and properdin. These 3 pathways all share a common terminal pathway consisting of C5 to C9. The final outcome of the late pathway is to form a MAC that penetrates the cell membrane and facilitates cell death by lysis. Opsonization is the process of&#x000a0;utilizing cleaved components of complement, C3b, and C4b, whereas inflammation is the process utilizing C3a and C5a, as anaphylatoxins.</p>
        <p>Complement activity is regulated by an intricate system. The important components of this system include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Complement receptor 1 (CR1)</p>
          </list-item>
          <list-item>
            <p>Complement receptor 2 (CR2)</p>
          </list-item>
          <list-item>
            <p>Decay accelerating factor (DAF)</p>
          </list-item>
        </list>
        <p>A North African study&#x000a0;looking into the basis of complement factor I deficiency in cases of atypical hemolytic and uremic syndrome observed that the Ile357Met mutation could be a founding effect.<xref ref-type="bibr" rid="article-19785.r13">[13]</xref></p>
        <p>There are&#x000a0;cell surface-associated proteins and plasma proteins that regulate&#x000a0;different steps of the complement pathways; for instance, factor H and factor I stop the formation of C3 convertase in the alternative pathway. The enzyme C1q esterase inhibits serine proteases C1r and C1s of the classic pathway. The deficiency of these regulatory proteins leads to the overactivation of the complement system and an abundance of damaging inflammatory effects.<xref ref-type="bibr" rid="article-19785.r14">[14]</xref>&#x000a0;Two clinical&#x000a0;conditions due to these&#x000a0;deficiencies are paroxysmal nocturnal hemoglobinuria (PNH) and hereditary angioedema. A sampling of thirteen patients of hereditary angioedema, mainly women younger than 50 years, with low or normal levels of C1 inhibitor who&#x000a0;got COVID-19, had neither severe COVID-19 nor severe acute angioedema.<xref ref-type="bibr" rid="article-19785.r15">[15]</xref></p>
      </sec>
      <sec id="article-19785.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The history is the most important initial diagnostic tool for ruling out complement immunodeficiency. Recurrent Neisseria infection indicates possible late complement deficiencies (C5-C9) and early alternative pathway (properdin) deficiency. Severe recurrent pyogenic infection early in life should be an indication to rule out C3 immunodeficiency.<xref ref-type="bibr" rid="article-19785.r16">[16]</xref>&#x000a0;Complement deficiency should also be suspected in a patient with recurrent sinopulmonary infection with normal humoral (antibody) immunity and with/without autoimmunity. Pyogenic infections and sepsis in children and neonates&#x000a0;may be an indication of mannan-binding lectin deficiency.</p>
        <p>Infants may&#x000a0;develop Leiner disease, which presents as wasting, recurrent diarrhea, and generalized seborrheic dermatitis. It is attributed to a pathology of C5. However, there are reports suggesting a role of diminished C3 and reduced neutrophil mobility.<xref ref-type="bibr" rid="article-19785.r17">[17]</xref><xref ref-type="bibr" rid="article-19785.r18">[18]</xref> Thus, the etiology of Leiner disease is multifactorial.</p>
        <p>There are three major pathophysiological sequelae of complement deficiencies:</p>
        <p>
<bold>Inadequate Opsonization</bold>
</p>
        <p>Opsonization is the process of&#x000a0;making a pathogenic organism easy to ingest by the macrophage system. Defects in C3b or its cleavage product C3bi can lead to inadequate opsonization. The following can be various presentations of inadequate opsonization:</p>
        <list list-type="bullet">
          <list-item>
            <p>Frequent sinopulmonary infections with pathogens such as&#x000a0;<italic toggle="yes">Streptococcus pneumonia</italic></p>
          </list-item>
          <list-item>
            <p>Autoimmune syndromes</p>
          </list-item>
          <list-item>
            <p>Encapsulated bacterial infections such as&#x000a0;<italic toggle="yes">Neisseria meningitides</italic>&#x000a0;and&#x000a0;<italic toggle="yes">S pneumoniae</italic></p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Saccharomyces cerevisiae</italic>
<xref ref-type="bibr" rid="article-19785.r19">[19]</xref>
</p>
          </list-item>
          <list-item>
            <p>Atypical hemolytic uremic syndrome</p>
          </list-item>
          <list-item>
            <p>Membranoproliferative glomerulonephritis</p>
          </list-item>
          <list-item>
            <p>Age-related macular degeneration</p>
          </list-item>
        </list>
        <p>
<bold>Defects in Cell Lysis</bold>
</p>
        <p>The defect in terminal cascade proteins also predisposes&#x000a0;individuals to infection; however, the clinical history in these cases is different. The following are some consequences of these defects:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infection at an older age as opposed to patients with other complement deficiencies</p>
          </list-item>
          <list-item>
            <p>Lack of protection against many other nonbacterial pathogens, such as viruses, fungi, and mycobacteria</p>
          </list-item>
        </list>
        <p>
<bold>Immune Complex Diseases</bold>
</p>
        <p>Patients with the classic pathway complement deficiencies are&#x000a0;more prone&#x000a0;to develop immune complex diseases. The following are some sequelae of such defects:</p>
        <list list-type="bullet">
          <list-item>
            <p>Seizures secondary to&#x000a0;neuropsychiatric systemic lupus erythematosus<xref ref-type="bibr" rid="article-19785.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>Antiphospholipid antibody syndrome</p>
          </list-item>
          <list-item>
            <p>Arterial thrombosis<xref ref-type="bibr" rid="article-19785.r21">[21]</xref></p>
          </list-item>
        </list>
        <p>The examination may be normal if the patient is not actively infected or has autoimmunity. In a patient&#x000a0;with active pneumococcal pneumonia, a physical exam&#x000a0;demonstrates&#x000a0;crackles or bronchial breath sounds on lung auscultation at peripheral lung fields. Egophony can be noted when significant consolidation is present.&#x000a0;Examination of patients with meningitis frequently reveals meningismus. Patients may have positive Kernig or Brudzinski signs that show meningeal irritation. Other signs of <italic toggle="yes">Neisseria meningitidis</italic> infection include petechial rash and, in severe cases, can present with septic shock or disseminated intravascular coagulation (DIC).<xref ref-type="bibr" rid="article-19785.r22">[22]</xref>&#x000a0;Patients with early classical complement deficiencies may present with swollen and/or inflamed joints, suggesting autoimmunity.</p>
      </sec>
      <sec id="article-19785.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Patients with recurrent infections of the respiratory tract without risk factors (negative human immunodeficiency virus, no asplenia, no other immunodeficiencies), as well as recurrent infections of encapsulated organisms such as Streptococcus pneumoniae, Neisseria meningitidis, and Hemophilus influenzae,&#x000a0;should be screened for complement deficiency.<xref ref-type="bibr" rid="article-19785.r23">[23]</xref>&#x000a0;Patients with family members who have the recurrent pneumococcal and meningococcal disease should also be screened.</p>
        <p>Screening for the complement system includes tests for the classical complement pathway (CH50), the alternate pathway (AH50), and the mannose-binding lectin (MBL) pathway (MBL by ELISA). Low CH50 and normal AH50 suggest early classical complement component (C1, C2, and C4) deficiency. Low AH50 with normal CH50 suggests a deficiency of early alternative complement pathway factors (factor B, factor D, and properdin). Low AH50 and low CH50 suggest common terminal complement (C3, C5, C6, C7, C8, or C9) deficiency. If CH50 and AH50 are both normal and the clinician still suspects complement deficiency, MBL functional assay is indicated to screen for MBL deficiency.<xref ref-type="bibr" rid="article-19785.r24">[24]</xref></p>
        <p>Consider performing a head CT scan before a lumbar puncture in a patient&#x000a0;suspected&#x000a0;to have meningitis.&#x000a0;Individuals&#x000a0;with classic complement pathway deficiencies&#x000a0;must be screened for&#x000a0;consequences of immune complex diseases with the help of urinalysis and a complete blood cell count. A lumbar puncture should&#x000a0;be performed&#x000a0;in cases suspected of having&#x000a0;possible meningitis to diagnose bacterial meningitis.</p>
      </sec>
      <sec id="article-19785.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Complement deficiency is not typically treated with complement protein supplementation due to the infeasibility of overly frequent infusions, the risk for bloodborne infections, and the risk of developing antibodies to exogenous complement proteins. This condition is managed on a case-by-case basis with antibiotics for each episode of infection as well as regular visits with their immunologist.<xref ref-type="bibr" rid="article-19785.r25">[25]</xref>&#x000a0;Due to this population&#x02019;s vulnerability to encapsulated organisms; patients need to be aware of the symptoms of meningococcal infection and&#x000a0;seek care&#x000a0;immediately if they should develop. Patients with complement deficiency should undergo all routine bacterial and viral vaccinations, especially meningococcal and pneumococcal vaccinations, and do not have a contraindication to live vaccines.<xref ref-type="bibr" rid="article-19785.r26">[26]</xref></p>
        <p>Some patients may develop flare-ups of their autoimmune disease. These patients should be managed with immunosuppressive therapy.</p>
      </sec>
      <sec id="article-19785.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for these recurrent infections broadly includes B cell immunodeficiency, combined immunodeficiency, acquired immunodeficiencies, as well as asplenia with a predisposition for encapsulated organisms. The list of differential diagnoses is:</p>
        <list list-type="bullet">
          <list-item>
            <p>Asplenia</p>
          </list-item>
          <list-item>
            <p>Common variable deficiency</p>
          </list-item>
          <list-item>
            <p>Hypogammaglobulinemia</p>
          </list-item>
          <list-item>
            <p>HIV</p>
          </list-item>
          <list-item>
            <p>Chronic granulomatous disease</p>
          </list-item>
          <list-item>
            <p>Chediak-Higashi syndrome</p>
          </list-item>
          <list-item>
            <p>Leukocyte adhesion deficiency</p>
          </list-item>
          <list-item>
            <p>Cyclic neutropenia</p>
          </list-item>
          <list-item>
            <p>SLE<xref ref-type="bibr" rid="article-19785.r27">[27]</xref></p>
          </list-item>
          <list-item>
            <p>Immunoglobulin A deficiency</p>
          </list-item>
          <list-item>
            <p>Immunoglobulin G deficiency</p>
          </list-item>
          <list-item>
            <p>Immunoglobulin D deficiency</p>
          </list-item>
          <list-item>
            <p>Immunoglobulin M deficiency</p>
          </list-item>
          <list-item>
            <p>Meningococcemia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19785.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of this condition depends on the recurrence of infections as well as the severity of the episode of infection at the time. Many of these patients are at high risk for meningitis which can be life-threatening if untreated.<xref ref-type="bibr" rid="article-19785.r22">[22]</xref></p>
      </sec>
      <sec id="article-19785.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications include severe pneumococcal and meningococcal infections that can be fatal if not evaluated and treated adequately. Patients may also develop autoimmune disorders, especially systemic lupus erythematosus.</p>
      </sec>
      <sec id="article-19785.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients with recurrent pneumococcal and/or meningococcal infections without predisposing risk factors should be referred to the allergist/immunologist.&#x000a0;Also, consider consulting&#x000a0;an infectious disease specialist or a rheumatologist to help&#x000a0;treat acute complications of the complement deficiencies.</p>
      </sec>
      <sec id="article-19785.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients and parents should be educated on the symptoms of serious illness, including meningitis, pneumonia, and sepsis. They should be instructed to seek care immediately if any of these signs develop. They should also seek care early for milder infections so that appropriate antibiotics can be started, and patients may be given prophylactic antibiotics for sudden recurrences. Vaccination is an important preventive measure, especially vaccination to prevent meningococcal and pneumococcal infections.</p>
        <p>Relatives of patients with complement deficiency should undergo complement screening as a diagnosis may&#x000a0;allow prophylaxis to prevent possible disabling or life-threatening infections.<xref ref-type="bibr" rid="article-19785.r28">[28]</xref>&#x000a0;Complement deficiency should be looked for in adults with&#x000a0;<italic toggle="yes">N meningitidis</italic>&#x000a0;infection.<xref ref-type="bibr" rid="article-19785.r23">[23]</xref>&#x000a0;Early diagnosis, antibiotic prophylaxis, and the use of vaccinations may allow normal life in hereditary C2 deficiency.<xref ref-type="bibr" rid="article-19785.r29">[29]</xref><xref ref-type="bibr" rid="article-19785.r7">[7]</xref></p>
      </sec>
      <sec id="article-19785.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Complement deficiency can lead to life-threatening infections as well as long-term autoimmune conditions and organ injuries. The interprofessional team of the primary care clinician and emergency medicine&#x000a0;clinician must be aware of the clinical features of patients with complement deficiency or immunodeficiency in general. Relying on acute treatment when the patient is acutely ill may not be adequate to improve the patient's quality of life and clinical outcome. A high index of suspicion is important, and early referral to allergist/immunologists may be important when the diagnosis of immunodeficiency is not clear.</p>
      </sec>
      <sec id="article-19785.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19785&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19785">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19785/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19785">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-19785.s16">
        <fig id="article-19785.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Complement Cascade Schematic Diagram Contributed by L Wen, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Schematic__of__complement__activations" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-19785.s17">
        <title>References</title>
        <ref id="article-19785.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000fc;ller-Eberhard</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Complement.</article-title>
            <source>Annu Rev Biochem</source>
            <year>1975</year>
            <volume>44</volume>
            <fpage>697</fpage>
            <page-range>697-724</page-range>
            <pub-id pub-id-type="pmid">1094920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schr&#x000f6;der-Braunstein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kirschfink</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management.</article-title>
            <source>Mol Immunol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>114</volume>
            <fpage>299</fpage>
            <page-range>299-311</page-range>
            <pub-id pub-id-type="pmid">31421540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blanco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pellegrin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Moreau</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Viallard</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>[Pathophysiology of systemic lupus erythematosus].</article-title>
            <source>Presse Med</source>
            <year>2007</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5 Pt 2</issue>
            <fpage>825</fpage>
            <page-range>825-34</page-range>
            <pub-id pub-id-type="pmid">17449371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Contin-Bordes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lazaro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pellegrin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Viallard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Moreau</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Systemic lupus erythematosus: from pathophysiology to treatment].</article-title>
            <source>Rev Med Interne</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>30</volume>
            <issue>12 Suppl</issue>
            <fpage>H9</fpage>
            <page-range>H9-13</page-range>
            <pub-id pub-id-type="pmid">19995652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skattum</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van Deuren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van der Poll</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Truedsson</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Complement deficiency states and associated infections.</article-title>
            <source>Mol Immunol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>14</issue>
            <fpage>1643</fpage>
            <page-range>1643-55</page-range>
            <pub-id pub-id-type="pmid">21624663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JX</given-names>
              </name>
              <name>
                <surname>Yusin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Randhawa</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Properdin deficiency-associated bronchiectasis.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>112</volume>
            <issue>6</issue>
            <fpage>557</fpage>
            <page-range>557-9</page-range>
            <pub-id pub-id-type="pmid">24793003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>J&#x000f6;nsson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hansson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mellhammar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gullstrand</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bengtsson</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Sahl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Skattum</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism.</article-title>
            <source>Vaccine</source>
            <year>2021</year>
            <month>Feb</month>
            <day>22</day>
            <volume>39</volume>
            <issue>8</issue>
            <fpage>1297</fpage>
            <page-range>1297-1302</page-range>
            <pub-id pub-id-type="pmid">33509693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Chase</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Densen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hintermeyer</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Casper</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Atkinson</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Autoantibody stabilization of the classical pathway C3 convertase leading to C3 deficiency and Neisserial sepsis: C4 nephritic factor revisited.</article-title>
            <source>Clin Immunol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>145</volume>
            <issue>3</issue>
            <fpage>241</fpage>
            <page-range>241-50</page-range>
            <pub-id pub-id-type="pmid">23117396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Cortes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pangburn</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Ram</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.</article-title>
            <source>J Immunol</source>
            <year>2010</year>
            <month>Jul</month>
            <day>01</day>
            <volume>185</volume>
            <issue>1</issue>
            <fpage>507</fpage>
            <page-range>507-16</page-range>
            <pub-id pub-id-type="pmid">20530262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bryan</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Complement deficiencies in systemic lupus erythematosus.</article-title>
            <source>Curr Allergy Asthma Rep</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>7</issue>
            <fpage>448</fpage>
            <pub-id pub-id-type="pmid">24816552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grumach</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Kirschfink</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach.</article-title>
            <source>Mol Immunol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>61</volume>
            <issue>2</issue>
            <fpage>110</fpage>
            <page-range>110-7</page-range>
            <pub-id pub-id-type="pmid">25037634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gigli</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Immunochemistry and immunobiology of the complement system.</article-title>
            <source>J Invest Dermatol</source>
            <year>1976</year>
            <month>Sep</month>
            <volume>67</volume>
            <issue>3</issue>
            <fpage>346</fpage>
            <page-range>346-53</page-range>
            <pub-id pub-id-type="pmid">787430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jlajla</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dehman</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jallouli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khedher</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ayadi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zerzeri</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Laadhar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sfar</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mahfoudh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gorgi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cheour</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zouaghi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gargah</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kallel Sellami</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Molecular basis of complement factor I deficiency in Tunisian atypical haemolytic and uraemic syndrome patients.</article-title>
            <source>Nephrology (Carlton)</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>357</fpage>
            <page-range>357-364</page-range>
            <pub-id pub-id-type="pmid">29292855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roumenina</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>S&#x000e8;ne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Radanova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blouin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Halbwachs-Mecarelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dragon-Durey</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fridman</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Fremeaux-Bacchi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance.</article-title>
            <source>J Immunol</source>
            <year>2011</year>
            <month>Oct</month>
            <day>15</day>
            <volume>187</volume>
            <issue>8</issue>
            <fpage>4369</fpage>
            <page-range>4369-73</page-range>
            <pub-id pub-id-type="pmid">21930969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grumach</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Goudouris</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dortas Junior</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marcelino</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>MLO</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Arpon</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Valle</surname>
                <given-names>SOR</given-names>
              </name>
            </person-group>
            <article-title>COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>508</fpage>
            <page-range>508-510</page-range>
            <pub-id pub-id-type="pmid">33271349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schur</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Inherited complement component abnormalities.</article-title>
            <source>Annu Rev Med</source>
            <year>1986</year>
            <volume>37</volume>
            <fpage>333</fpage>
            <page-range>333-46</page-range>
            <pub-id pub-id-type="pmid">3010807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sonea</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Moroz</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Reece</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Leiner's disease associated with diminished third component of complement.</article-title>
            <source>Pediatr Dermatol</source>
            <year>1987</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>105</fpage>
            <page-range>105-7</page-range>
            <pub-id pub-id-type="pmid">2958789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goodyear</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Leiner's disease associated with metabolic acidosis.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>1989</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>364</fpage>
            <page-range>364-6</page-range>
            <pub-id pub-id-type="pmid">2532987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Degn</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Jensenius</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Thiel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Disease-causing mutations in genes of the complement system.</article-title>
            <source>Am J Hum Genet</source>
            <year>2011</year>
            <month>Jun</month>
            <day>10</day>
            <volume>88</volume>
            <issue>6</issue>
            <fpage>689</fpage>
            <page-range>689-705</page-range>
            <pub-id pub-id-type="pmid">21664996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Schaarenburg</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Magro-Checa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Teng</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Bajema</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Huizinga</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Steup-Beekman</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Trouw</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus.</article-title>
            <source>Front Immunol</source>
            <year>2016</year>
            <volume>7</volume>
            <fpage>647</fpage>
            <pub-id pub-id-type="pmid">28082982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peerschke</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Alpert</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Roubey</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Salmon</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ghebrehiwet</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies.</article-title>
            <source>Lupus</source>
            <year>2009</year>
            <month>May</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>530</fpage>
            <page-range>530-8</page-range>
            <pub-id pub-id-type="pmid">19395455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Ram</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Meningococcal disease and the complement system.</article-title>
            <source>Virulence</source>
            <year>2014</year>
            <month>Jan</month>
            <day>01</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-126</page-range>
            <pub-id pub-id-type="pmid">24104403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Audemard-Verger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Descloux</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ponard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Deroux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fantin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fieschi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bouldouyre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karkowsi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moulis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Auvinet</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Valla</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lechiche</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Davido</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Martinot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Biron</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lucht</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Asseray</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Froissart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Buzel&#x000e9;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Perlat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boutboul</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fremeaux-Bacchi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Isnard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bienvenu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2016</year>
            <month>May</month>
            <volume>95</volume>
            <issue>19</issue>
            <fpage>e3548</fpage>
            <pub-id pub-id-type="pmid">27175654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ekdahl</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Persson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mohlin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sandholm</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Skattum</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Interpretation of Serological Complement Biomarkers in Disease.</article-title>
            <source>Front Immunol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>2237</fpage>
            <pub-id pub-id-type="pmid">30405598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ram</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Infections of people with complement deficiencies and patients who have undergone splenectomy.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>740</fpage>
            <page-range>740-80</page-range>
            <pub-id pub-id-type="pmid">20930072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sobh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Vaccination in Primary Immunodeficiency Disorders.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2016</year>
            <season>Nov-Dec</season>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>1066</fpage>
            <page-range>1066-1075</page-range>
            <pub-id pub-id-type="pmid">27836056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x00171;zes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sipos</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>[Primary immunodeficiency and autoimmune diseases].</article-title>
            <source>Orv Hetil</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>159</volume>
            <issue>23</issue>
            <fpage>908</fpage>
            <page-range>908-918</page-range>
            <pub-id pub-id-type="pmid">29860882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dellepiane</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Dell'Era</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pavesi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Macor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Maso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pietrogrande</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Cugno</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2016</year>
            <month>May</month>
            <day>17</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <pub-id pub-id-type="pmid">27183977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19785.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dellepiane</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Baselli</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cazzaniga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lougaris</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Macor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gualtierotti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cugno</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hereditary Deficiency of the Second Component of Complement: Early Diagnosis and 21-Year Follow-Up of a Family.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2020</year>
            <month>Mar</month>
            <day>10</day>
            <volume>56</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">32164349</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
